Form: 20-F

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Exhibit 8.1

Kazia Therapeutics Limited has the following subsidiary companies

 

Subsidiary name

   Shareholding     Company of
incorporation
 

Kazia Laboratories Pty Limited

     100     Australia  

Kazia Research Pty Limited

     100     Australia  

Kazia Therapeutics Inc

     100     USA  

Glioblast Pty Limited

     100     Australia